Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MYL5 |
| Upstream (Parents) |
|---|
| (<<) PPP6R2 → MYL5 |
| (<<) BTD → MYL5 |
| (<<) FDXR → MYL5 |
| (<<) RFNG → MYL5 |
| Downstream (Children) |
|---|
| MYL5 → STAMBPL1 (>>) |
| MYL5 → POU3F4 (>>) |
| MYL5 → THAP9 (>>) |
| MYL5 → KIAA1731 (>>) |
| MYL5 → DCTN1 (>>) |
| MYL5 → FBXO21 (>>) |
| MYL5 → DOPEY2 (>>) |
| MYL5 → LOC157627 (>>) |
| MYL5 → TAS2R14 (>>) |
| MYL5 → CNN3P1///LOC285780 (>>) |
| MYL5 → PMS2L2 (>>) |
| MYL5 → FGF6 (>>) |
